Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Global Medical Cannabis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
6.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
6.2.3. By Distribution Channel (B2B, B2C)
6.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
6.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
6.2.6. By Region
6.2.7. By Company (2022)
6.3. Product Map
6.3.1 By Product Type
6.3.2 By Active Ingredient
6.3.3 By Distribution Channel
6.3.4 By Application
6.3.5 By End User
6.3.4 By Region
7. North America Medical Cannabis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
7.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
7.2.3. By Distribution Channel (B2B, B2C)
7.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
7.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Medical Cannabis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Active Ingredient
7.3.1.2.3. By Distribution Channel
7.3.1.2.4. By Application
7.3.1.2.5. By End User Industry
7.3.2. Canada Medical Cannabis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Active Ingredient
7.3.2.2.3. By Distribution Channel
7.3.2.2.4. By Application
7.3.2.2.5. By End User Industry
7.3.3. Mexico Medical Cannabis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Active Ingredient
7.3.3.2.3. By Distribution Channel
7.3.3.2.4. By Application
7.3.3.2.5. By End User Industry
8. Europe Medical Cannabis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
8.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
8.2.3. By Distribution Channel (B2B, B2C)
8.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
8.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. Germany Medical Cannabis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Active Ingredient
8.3.1.2.3. By Distribution Channel
8.3.1.2.4. By Application
8.3.1.2.5. By End User Industry
8.3.2. Malta Medical Cannabis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Active Ingredient
8.3.2.2.3. By Distribution Channel
8.3.2.2.4. By Application
8.3.2.2.5. By End User Industry
8.3.3. United Kingdom Medical Cannabis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecasty
8.3.3.2.1. By Product Type
8.3.3.2.2. By Active Ingredient
8.3.3.2.3. By Distribution Channel
8.3.3.2.4. B y Application
8.3.3.2.5. By End User Industry
8.3.4. France Medical Cannabis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Active Ingredient
8.3.4.2.3. By Distribution Channel
8.3.4.2.4. By Application
8.3.4.2.5. By End User Industry
8.3.5. Denmark Medical Cannabis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Active Ingredient
8.3.5.2.3. By Distribution Channel
8.3.5.2.4. By Application
8.3.5.2.5. By End User Industry
8.3.6. Italy Medical Cannabis Market Outlook
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Product Type
8.3.6.2.2. By Active Ingredient
8.3.6.2.3. By Distribution Channel
8.3.6.2.4. By Application
8.3.6.2.5. By End User Industry
8.3.7. Spain Medical Cannabis Market Outlook
8.3.7.1. Market Size & Forecast
8.3.7.1.1. By Value
8.3.7.2. Market Share & Forecast
8.3.7.2.1. By Product Type
8.3.7.2.2. By Active Ingredient
8.3.7.2.3. By Distribution Channel
8.3.7.2.4. By Application
8.3.7.2.5. By End User Industry
9. Asia-Pacific Medical Cannabis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
9.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
9.2.3. By Distribution Channel (B2B, B2C)
9.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
9.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. Australia Medical Cannabis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Active Ingredient
9.3.1.2.3. By Distribution Channel
9.3.1.2.4. By Application
9.3.1.2.5. By End User Industry
9.3.2. China Medical Cannabis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Active Ingredient
9.3.2.2.3. By Distribution Channel
9.3.2.2.4. By Application
9.3.2.2.5. By End User Industry
9.3.3. Thailand Medical Cannabis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Active Ingredient
9.3.3.2.3. By Distribution Channel
9.3.3.2.4. By Application
9.3.3.2.5. By End User Industry
9.3.4. South Korea Medical Cannabis Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product Type
9.3.4.2.2. By Active Ingredient
9.3.4.2.3. By Distribution Channel
9.3.4.2.4. By Application
9.3.4.2.5. By End User Industry
9.3.5. India Medical Cannabis Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product Type
9.3.5.2.2. By Active Ingredient
9.3.5.2.3. By Distribution Channel
9.3.5.2.4. By Application
9.3.5.2.5. By End User Industry
10. South America Medical Cannabis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
10.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
10.2.3. By Distribution Channel (B2B, B2C)
10.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
10.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Medical Cannabis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Active Ingredient
10.3.1.2.3. By Distribution Channel
10.3.1.2.4. By Application
10.3.1.2.5. By End User Industry
10.3.2. Argentina Medical Cannabis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Active Ingredient
10.3.2.2.3. By Distribution Channel
10.3.2.2.4. By Application
10.3.2.2.5. By End User Industry
10.3.3. Colombia Medical Cannabis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Active Ingredient
10.3.3.2.3. By Distribution Channel
10.3.3.2.4. By Application
10.3.3.2.5. By End User Industry
11. Middle East and Africa Medical Cannabis Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product Type (Buds/Marijuana Flower, Cannabis Extracts)
11.2.2. By Active Ingredient (Tetrahydrocannabinol (THC), Cannabidiol (CBD), Others)
11.2.3. By Distribution Channel (B2B, B2C)
11.2.4. By Application (Chronic Pain, Mental Disorders, Cancer, Epilepsy, Others)
11.2.5. By End User Industry (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. Lebanon Medical Cannabis Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product Type
11.3.1.2.2. By Active Ingredient
11.3.1.2.3. By Distribution Channel
11.3.1.2.4. By Application
11.3.1.2.5. By End User Industry
11.3.2. South Africa Medical Cannabis Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product Type
11.3.2.2.2. By Active Ingredient
11.3.2.2.3. By Distribution Channel
11.3.2.2.4. By Application
11.3.2.2.5. By End User Industry
11.3.3. Israel Medical Cannabis Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product Type
11.3.3.2.2. By Active Ingredient
11.3.3.2.3. By Distribution Channel
11.3.3.2.4. By Application
11.3.3.2.5. By End User Industry
12. Market Dynamics
12.1. Drivers
12.1.1 High prevalence of Chronic
12.1.2 Legalization of Medical Cannabis
12.2. Challenges
12.2.1 High cost and not always readily available
12.2.2 Less acceptance by the Consumer
13. Market Trends & Developments
13.1. New Product Development
13.2. Increasing use of Medical Cannabis by the medicinal and pharmaceutical industries.
14. Global Medical Cannabis Market: SWOT Analysis
15. Porter’s Five Forces Analysis
15.1. Competition in the Industry
15.2. Potential of New Entrants
15.3. Power of Suppliers
15.4. Power of Customers
15.5. Threat of Substitute Products
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.6. SWOT Analysis
16.6.1.1. Canopy Growth Corporation
16.6.1.2. Aphria, Inc.
16.6.1.3. Maricann Group, Inc
16.6.1.4. Tikun Olam - Cannabit Pharmaceuticals Ltd
16.6.1.5. MedReleaf. Corp
16.6.1.6. GW Pharmaceuticals plc.
16.6.1.7. Cannabis Sativa, Inc.
16.6.1.8. Medical Marijuana, Inc
16.6.1.9. Aurora Marijuana Inc.
16.6.1.10. Cronos Group Inc.
17. Strategic Recommendation